Blood Phenylalanine Trajectory and Executive Function Outcomes in Individuals with Phenylketonuria by Tardiff, Clarissa
Washington University in St. Louis 
Washington University Open Scholarship 
Arts & Sciences Electronic Theses and 
Dissertations Arts & Sciences 
Spring 4-6-2021 
Blood Phenylalanine Trajectory and Executive Function Outcomes 
in Individuals with Phenylketonuria 
Clarissa Tardiff 
Washington University in St. Louis 
Follow this and additional works at: https://openscholarship.wustl.edu/art_sci_etds 
 Part of the Clinical Psychology Commons 
Recommended Citation 
Tardiff, Clarissa, "Blood Phenylalanine Trajectory and Executive Function Outcomes in Individuals with 
Phenylketonuria" (2021). Arts & Sciences Electronic Theses and Dissertations. 2290. 
https://openscholarship.wustl.edu/art_sci_etds/2290 
This Thesis is brought to you for free and open access by the Arts & Sciences at Washington University Open 
Scholarship. It has been accepted for inclusion in Arts & Sciences Electronic Theses and Dissertations by an 
authorized administrator of Washington University Open Scholarship. For more information, please contact 
digital@wumail.wustl.edu. 
WASHINGTON UNIVERSITY IN ST. LOUIS 
 











Blood Phenylalanine Trajectory and Executive Function Outcomes  
in Individuals with Phenylketonuria 
by 









A thesis presented to 
the Graduate School 
of Washington University in 
partial fulfillment of the 
requirements for the degree 





















































Table of Contents 
 
List of Tables .................................................................................................................................iii 


































List of Tables 
Table 1. Demographic Information................................................................................................23 
Table 2. Hierarchical Linear Model for Age Effect on Blood Phe................................................24 
Table 3. Hierarchical Linear Model for Age and Semantic Clustering  
  Effect on Blood Phe……………………..………………......……………………….....25 
Table 4. Hierarchical Linear Model for Age and Recognition  
  Span Effect on Blood Phe………………………………………………....……………26 
Table 5. Hierarchical Linear Model for Age and N-Back Effect on Blood Phe…………………27 

























List of Figures 
Figure 1. Semantic Clustering Task...............................................................................................29 
Figure 2. Recognition Span Task...................................................................................................30 
Figure 3. N-Back Task...................................................................................................................31 
Figure 4. Go-No-Go Task..............................................................................................................32 
Figure 5. Effect of Age on Blood Phe............................................................................................33 
Figure 6. Effect of Age and Semantic Clustering Score on Blood Phe.........................................34 
Figure 7. Effect of Age and Recognition Span Score on Blood Phe.............................................35 
Figure 8. Effect of Age and N-Back Errors on Blood Phe............................................................36 























I would like to thank, first and foremost, my faculty advisor, Dr. Desirée White, for her 
constant encouragement and support during my thesis work and always. I would also like to 
thank Dr. Michael Strube for his critical input to my statistical analyses, as well as Dr. Lori 
Markson for serving on my thesis committee. Furthermore, I would like to thank fellow graduate 
student Zoë Hawks for her expert guidance throughout this project, without which this project 
could have never been actualized. I would also like to thank lab manager Suzin Blankenship and 
former graduate student Anna Hood for their contributions collecting and scoring the data for 
this project. Finally, I would like to thank my husband, John, for his constant love and support. 
This research was supported by a grant from the National Institute of Child Health and Human 
Development (R01HD044901).  
Clarissa T. Tardiff 
















ABSTRACT OF THE THESIS 
Blood Phenylalanine Trajectory and Executive Function Outcomes  
in Individuals with Phenylketonuria 
by 
Clarissa T. Tardiff 
Master’s of Arts in Psychology 
Washington University in St. Louis, 2017 
Professor Desirée White, Chair 
Phenylketonuria (PKU) is an autosomal recessive disorder characterized by mutations in 
phenylalanine hydroxylase genes. As a result, phenylalanine (Phe) metabolism is disrupted, and 
this amino acid accumulates in blood and tissue (Pietz, 1998; Scriver et al., 2000). Although the 
most severe symptoms of PKU may be avoided by early detection and treatment, many 
individuals with early-treated PKU still experience difficulties in executive function, attention, 
and processing speed (Antenor-Dorsey et al., 2013; Araujo et al., 2013; Christ et al., 2020; 
Hawks, Strube, Johnson, Grange, & White, 2018; Hood, Grange, Christ, Steiner, & White, 2014; 
Janos et al., 2012; White et al., 2002). Of particular relevance to the current investigation are the 
executive abilities of strategic processing, working memory, and inhibition. The present study is 
the first to investigate the rate of blood Phe level increase as a function of increasing age and its 
relationship to these executive abilities, with the hypothesis that a greater rate of change is 
associated with poorer executive performance. Repeated blood Phe measures were collected 
from children ages 0-24 years of age with early- and continuously-treated PKU whose executive 
abilities were assessed (n = 73, males = 37, females = 36, mean age at assessment = 14.3 years). 
The relationships between blood Phe and semantic clustering scores (strategic processing), 
vii 
 
recognition span scores, n-back errors (working memory), and go-no-go commission errors 
(inhibition), as well as their interactions with age, were examined using hierarchical linear 
modeling to account for longitudinal dependencies. Consistent with hypotheses, better semantic 
clustering and recognition span scores were associated with less increase in blood Phe as age 
increased, whereas more n-back and go-no-go errors were associated with greater increase in 
blood Phe as age increased. Continued efforts to specify the time frame during which rates of 
blood Phe increase and executive performance are most strongly related will aid in identifying 
developmental periods during which PKU treatment adherence may be especially important for 


















Phenylketonuria (PKU) is an autosomal recessive disorder characterized by mutations in 
the phenylalanine hydroxylase gene. This mutation inhibits the metabolism of phenylalanine 
(Phe), which is a critical amino acid found in all proteins, into the amino acid tyrosine and results 
in the buildup of Phe in blood and tissue (Pietz, 1998; Scriver et al., 2000). Because tyrosine is a 
precursor of catecholamines, PKU is associated with deficiencies in dopamine and other 
catecholamines (Curtius et al., 1981; Diamond, Ciaramitaro, Donner, Djali, & Robinson, 1994; 
Krause, Epstein, Averbook, Dembure, & Elsas, 1986; White, Nortz, Mandernach, Huntington, & 
Steiner, 2001).  
If left untreated, PKU is associated with severe mental retardation (IQ<30), seizures, and 
severe behavioral difficulty (Jervis, 1937, 1954; Paine, 1957). The incidence of PKU varies 
globally, but is 1:10,000 in North America (Scriver, 2001). Fortunately, the most severe 
symptoms can be prevented through neonatal screening and early treatment (Holtzman, 
Kronmal, van Doorninck, Azen, Kochet, 1986; Michals, Azen, Acosta, Koch, Matalon, 1988; 
National Institutes of Health, 2001). The primary treatment for PKU is dietary restriction of Phe 
consumption, with significant limitations on high Phe foods such as meat, fish, dairy products, 
nuts, and beans (Singh et al., 2014). This diet is quite burdensome, and lapses in adherence are 
common (Bilginsoy, Waitzman, Leonard, & Ernst, 2005; Fisch, 2000; Gassió et al., 2003; 
Matalon, Michals, & Gleason, 1986; Mütze et al., 2011; Prince, McMurray, & Buist, 1997; 
Waisbren, Hamilton, St James, Shiloh, & Levy, 1995; Walter et al., 2002).  
Even with neonatal screening and early treatment, individuals with PKU exhibit brain 
abnormalities (Anderson & Leuzzi, 2010; Antenor-Dorsey et al., 2013; Bodner et al., 2012; 
Christ et al., 2016), lower scores on intelligence tests (Ris, Williams, Hunt, Berry, & Leslie, 
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1994; Waisbren et al., 2007), psychosocial and psychiatric difficulties (Brumm, Bilder, & 
Waisbren, 2010; Gentile, Hoedt, & Bosch, 2010; Weglage et al., 2000), and executive deficits 
(Christ, Huijbregts, de Sonneville, & White, 2010). Although the precise mechanisms resulting 
in the cognitive deficits experienced by people with PKU are unknown, it is generally accepted 
that they are related to elevations in blood Phe at various life stages (Hofman, Champ, Lawton, 
Henderson, & Dye, 2018). Cognitive outcomes have especially been associated with blood Phe 
levels in early childhood through adolescence, and of particular interest to this study is the 
demonstrated negative relationship between blood Phe and executive function (Brunner, Jordan, 
& Berry, 1983; Christ et al., 2020; Diamond, Prevor, Callender, & Druin, 1997; Hofman et al., 
2018; Huijbregts et al., 2002; Waisbren, Mahon, Schnell, & Levy, 1987; Weglage, Pietsch, 
Funder, Koch, & Ullrich, 1996; Welsh, Pennington, Ozonoff, Rouse, & McCabe, 1990). 
Executive function is defined as a collection of higher order cognitive abilities including 
response monitoring, working memory, strategic processing, and inhibition (Goldstein & 
Naglieri, 2013).  Although executive function improves as typically developing children age 
(Zelazo et al., 2013), deficits in executive function have been widely observed in children and 
adults with PKU and become increasingly pronounced as children age (Albrecht, Garbade, & 
Burgard, 2009; Bilder et al., 2016; DeRoche & Welsh, 2008; White et al., 2001). Prefrontal 
cortex dysfunction is believed to underlie the impairments in executive function among 
individuals with PKU (Christ, Steiner, Grange, Abrams, & White, 2006; Diamond et al., 1997; 
White et al., 2001; White, Nortz, Mandernach, Huntington, & Steiner, 2002).  
Of particular relevance to the current investigation are the executive abilities of strategic 
processing, working memory, and inhibition. First, strategic processing, which is the ability to 
evaluate and alter plans to perform cognitive and behavioral tasks efficiently, has been found to 
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be poorer in children with PKU, especially older children (De Felice, Romani, Geberhiwot, 
MacDonald, Palermo, 2018; Nardecchia et al., 2015; White et al., 2001). There is evidence that 
higher blood Phe during childhood is associated with poorer strategic processing in adulthood 
(Bartus et al., 2018; Jahja et al., 2017).  
Secondly, working memory involves the maintenance and manipulation of information 
for brief periods of time during cognitive task performance (Baddeley 1986). This ability has 
also been found to be poorer among individuals with PKU (Bartus et al., 2018; Brumm et al., 
2004; Channon, German, & Lee, 2004; Christ et al., 2020; Jahja et al., 2017; Palermo et al., 
2017). Furthermore, the age-related improvements in working memory that are observed in 
typically developing children has not been found in children with PKU (White et al., 2001). As 
for the relationship between blood Phe and working memory, high blood Phe has been associated 
with poorer working memory (Channon et al., 2004; Channon, Goodman, Zlotowitz, Mockler, & 
Lee, 2007). 
Finally, inhibition is the ability to suppress thought processes, actions, or expressions that 
would interfere with attainment of a cognitive or behavioral goal (Carlson, Moses, & Breton, 
2002). Individuals with PKU have deficits in inhibition, as demonstrated by more commission 
errors (i.e., false alarms) on tests of inhibition compared with typically developing controls 
(Araujo et al., 2009, 2013). Relatedly, Wiersema, van der Meere, and Roeyers (2005) showed 
that children with PKU have a higher rate of attention deficit hyperactivity disorder than the 
general population. In terms of Phe, higher blood Phe has been associated with poorer inhibition 
(Jahja et. al., 2017; Romani, Palermo, MacDonald, Limback, & Hall, 2017). 
In the present study we wished to move beyond the simple relationships between blood 
Phe and executive function by examining the relationships among the rate of blood Phe change 
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over time and executive function. To do so, we collected blood Phe measurements over time for 
each study participant from their medical record. In conjunction, executive function was assessed 




Children and adolescents ages 0-24 years with early- and continuously-treated PKU (n = 
73, males = 37, females = 36, mean age at assessment = 14.3 years) were recruited through 
metabolic clinics at St. Louis Children's Hospital, University of Missouri, University of Florida, 
St. Louis University, Washington University, New York Medical College, and University of 
Nebraska. All were assessed at Washington University in St. Louis (n = 35), University of 
Missouri Columbia (n = 10), or Oregon Health and Science University (n = 28). Demographic 
information is presented in Table 1.  
Procedure 
As a measure of long-term memory and strategic processing, a word list task (see Figure 
1) was administered (n = 65, mean age at assessment = 13.9 years). During this task, participants 
listened as an examiner read a list of 18 words at a pace of 1 word per second and then recalled 
the list over 5 learning trials. Each list comprised items from different semantic categories (e.g., 
fruit, clothing, toys) such that there were 6 words from each category. Following presentation of 
the list, participants were asked to recall the words in any order. Memory of the items after a 20-
minute delay was also assessed. The strategic processing variable of interest was semantic 
clustering, which indicates words that were sequentially reported from the same semantic 
category when individuals recalled words from the list. For example, “banana, watermelon, 
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strawberries, hat, belt, shorts” counted as two clusters (one fruit cluster, one clothing cluster). 
The average number of semantic clusters across all trials was used in analyses. 
To assess working memory, a recognition span task (n = 27, mean age at assessment = 
16.8 years) and an n-back task (n = 25, mean age at assessment = 16.7 years) were administered. 
During the recognition span task (see Figure 2), series of two to nine stimuli were presented 
within a grid on a computer monitor. There were two conditions, with one focusing on stimuli 
location and the other focusing on stimuli shape. Series comprising each condition were 
administered as a block. Stimuli within a series were presented one at a time, with each stimulus 
remaining on the monitor for 1250 ms. The interstimulus interval was 500 ms. Following the 
presentation of the last stimulus in a series, an array appeared that included all stimuli presented 
in that series. In the location condition, participants were asked to point to the locations in which 
stimuli appeared in the order in which they were presented. In the shape condition, participants 
were asked to point to the shapes that appeared in the order presented. The examiner depressed a 
right or left computer mouse button to record correct or incorrect responses, respectively. For 
each condition, 12 discrimination, 2 practice, and 18 experimental trials were administered. The 
average recognition span score across both conditions was used in analyses. 
During the n-back task (see Figure 3), individuals watched a computer monitor as one of 
nine letters (A, C, F, H, J, N, P, Q, and S) appeared in one of nine locations along an imaginary 
circle eccentric to central fixation. There were two conditions, with one focusing on stimuli 
identity (i.e., letter) and the other focusing on stimuli location. In the letter condition, participants 
were asked to press a target button when the letter was the same as that which was presented two 
trials ago (regardless of location). For the location condition, participants were asked to press a 
target button when the location was the same as that which was presented two trials ago 
6 
 
(regardless of letter identity). Individuals heard a “beep” following correct responses and a 
“buzz” following incorrect responses. For each condition, participants completed a practice 
block of 24 trials and then 98 experimental trials. The average number of errors across both 
conditions, including both false alarms (commission errors) and missed targets (omission errors), 
was used in analyses. 
As a measure of inhibition, participants completed a go-no-go task (see Figure 4) (n = 73, 
mean age at assessment = 14.3 years). There were two types of trials, with one focusing on go 
responses and the other focusing on no-go responses. On each trial, one of four stimuli (square, 
triangle, diamond, circle) was presented centrally on a computer monitor. One stimulus shape 
was designated as a non-target at the beginning of the task. Participants were asked to press a 
response button as quickly as possible when any stimulus appeared except the non-target. Go and 
no-go trials were randomly intermixed. If a participant failed to respond within 1500 ms on a go 
trial (omission error), a tone was presented. If an individual responded to a non-target 
(commission error), a tone was also presented. Participant completed 20 practice trials followed 
by 200 experimental trials. The number of responses to the non-target (i.e., number of 
commission errors) was used in analyses. 
Statistical Approach  
Analyses were conducted in R (R Core Team, 2019 using ggplot2 (Wickham, 2016), 
lmerTest (Kuznetsova, Brockhoff, & Christensen, 2017), dplyr (Wickham, François, Henry, & 
Müller, 2020), foreign (R Core Team, 2018), and interactions (Long, 2019). Hierarchical linear 
modeling was used to account for longitudinal dependencies (i.e., multiple blood Phe 
measurements nested within individuals) in the data.  Since blood Phe commonly increases in a 
non-linear fashion over early development (Walter & White, 2004), first, second, and third-order 
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polynomials models were tested. The second-order (quadratic) model was determined to be the 
best fit because it minimized AIC and BIC without overfitting. Blood Phe was a dependent 
variable, Age2 and Age were Level 1 variables, and executive function (EF) was a Level 2 
variable. Cross-level interactions (Age2 x  EF, Age x EF) were modeled, and continuous 
variables were grand mean centered. Intercept and slope were modeled as random effects. 
Results were considered statistically significant at p < 0.05.  
 
Results 
The results of all hierarchical linear models are reported in Tables 1-6 and illustrated in 
Figures 5-9.  As noted previously, age and executive scores were grand mean centered. Only the 
significant effects in the quadratic model will be discussed below. 
Age 
 When using age as a predictor in a fully random hierarchical linear model, the quadratic 
age term was significant (p < 0.001), indicating a quadratic increase of blood Phe as age 
increased. These results are reported in Table 2 and Figure 5. 
Strategic Processing 
With regard to strategic processing as measured by the semantic clustering score, two 
results were of interest. The quadratic age term was significant (p < .001), indicating a quadratic 
increase in blood Phe as age increased, at mean levels of age and semantic clustering. 
Furthermore, the quadratic interaction term between blood Phe and semantic clustering was 
significant (p < .001), signifying that higher semantic clustering scores were associated with a 
shallower slope in blood Phe increase over age as age increased. These results are reported in 




Two results related to working memory were also notable. The quadratic age term was 
significant (p = .020), indicating a quadratic increase in blood Phe as age increased, at mean 
levels of age and recognition span. The quadratic interaction term between blood Phe and 
recognition span score was also significant (p < .001). This indicated that higher recognition span 
scores were associated with a shallower slope in blood Phe increase over age as age increased. 
These results are reported in Table 4 and Figure 7. 
Regarding the n-back task model, the quadratic interaction term between blood Phe and 
n-back errors was also significant (p = .004). This indicated that higher numbers of n-back errors 
were associated with a steeper slope in blood Phe increase over age as age increases. These 
results are reported in Table 5 and Figure 8. 
Inhibition 
With regard to go-no-go performance, the quadratic age term was significant (p < .001), 
indicating a quadratic increase of blood Phe as age increased. The quadratic interaction term 
between blood Phe and go-no-go commission errors was also significant (p < .001). This 
indicated that higher go-no-no commission errors were associated with a steeper slope in blood 
Phe increase over age as age increased. These results are reported in Table 6 and Figure 9. 
 
Discussion 
The present study investigated the trajectory of blood Phe levels over time and its 
relationship with executive function by modeling blood Phe over age and incorporating 
executive abilities, specifically strategic processing, working memory, and inhibition, as 
predictors. The average raw number of semantic clusters on a word list learning task was used as 
a measure of strategic processing. The average raw number of stimuli remembered on a 
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recognition span task, as well as the average raw number of errors on an n-back task, were used 
as measures of working memory. Finally, the average raw number of commission errors on a go-
no-go task was used as a measure of inhibition. Data were analyzed using hierarchical linear 
modeling to account for longitudinal dependencies in the data and it was determined that the 
quadratic model best fit the slope of blood Phe over time. 
Although the effect of age and executive function interaction was of greatest interest, we 
first address the effect of age alone. The quadratic age term was significant in the quadratic 
model with age alone as a predictor, and also across all the executive function conditions except 
in the n-back task, demonstrating that when age was grand mean centered, blood Phe increased 
quadratically up to age 24 years. It is likely that this effect was not found in the n-back task due 
to the fact that a smaller number of participants completed that task. The quadratic models are 
consistent with and contribute to the current understanding of increases in blood Phe with age 
due to decreasing dietary limitations on Phe intake. As individuals with PKU grow older, they 
tend to take more control over their diet, which would have previously been managed by their 
parents. As they take control, there is also a tendency to relax their diet (Waisbren et al., 2007). 
With this in mind, it follows that blood Phe would increase quadratically.  
Next, we draw attention to the interaction of the quadratic age and executive function 
terms. Across all executive tasks, the interaction of age and executive abilities scores was 
significant at mean centered levels of age and executive scores. This indicated that, for 
participants who performed better on the strategic processing, working memory, and inhibition 
tasks, the relationship between age and blood Phe increased at a slower rate. More simply put, 




Previous research has examined the impact of blood Phe on executive function and has 
highlighted the need for individuals with PKU to limit their Phe intake for adequate executive 
function. In no research to date, however, has the impact of the rate of blood Phe increase over 
time on executive function been examined. As our results indicate, the rate of blood Phe increase 
is an important predictor of executive function. Individuals with PKU, their families, and their 
healthcare providers should take this into consideration when planning dietary management and 
adherence to dietary prescriptions over time, especially during childhood and adolescence. 
In terms of limitations, the age of our participants was restricted to 0-24 years because 
that is when blood Phe is known to change most significantly. It is likely that, after age 24 years, 
blood Phe plateaus and the present quadratic model will not be sufficient. Furthermore, the 
present study only examined the relationship between blood Phe trajectory and executive 
function when age was grand mean centered (age = 5.0395). It would be informative to center 
age at different points to determine the age range at which the rate of blood Phe increase is most 
strongly predicted by executive function. Practically, determining a specific age period during 
which rate of blood Phe increase is most negatively related to executive function could point to 
periods during which dietary management is most important for executive function. 
 
Conclusion 
Our results indicated that children and adolescents with PKU exhibited a quadratic 
increase in blood Phe up to age 24 years when age was mean centered at 5. More importantly, 
the interaction of age and executive function, at mean centered levels of age and executive 
function score, indicated that the rate of increase in blood Phe predicted later executive function. 
This finding has practical implications for dietary restriction during childhood. Although strict 
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adherence to diet has always been recommended to manage PKU, its importance is emphasized 
by the knowledge of the predictive importance of rates of blood Phe increase over time. 
Continued efforts to specify the time frame during which rates of blood Phe have the strongest 
effect on executive function outcomes will provide individuals with PKU, their families, and 
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Tables and Figures 
 
Table 1. Demographic information, grouped by participants in overall pool and for each 
executive abilities task. 

















All 73 37 36 7.09 3.42 5.04 14.29 
Semantic 
Clustering 
65 31 34 6.85 3.22 5.13 13.90 
Recognition 
Span 
27 17 10 8.03 3.65 4.87 16.81 
N-Back 25 15 10 7.88 3.61 4.87 16.72 
Go-No-Go 73 37 36 7.09 3.42 5.04 14.29 
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Table 3. Hierarchical Linear Model for Age and Semantic Clustering Effect on Blood Phe, Data 




















Table 4. Hierarchical Linear Model for Age and Recognition Span Effect on Blood Phe, Data 



















Table 5. Hierarchical Linear Model for Age and N-Back Effect on Blood Phe, Data Nested 






















Table 6. Hierarchical Linear Model for Age and Go-No-Go Effect on Blood Phe, Data Nested 















































































































































































































Figure 9. Effect of Age and Go-No-Go Commission Errors on Blood Phe 
 
